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Staphylococcus aureus is a frequent commensal but also a dangerous pathogen, causing many
forms of infection ranging from mild to life-threatening conditions. Among its virulence
factors are lipoproteins, which are anchored in the bacterial cell membrane. Lipoproteins
perform various functions in colonization, immune evasion, and immunomodulation. These
proteins are potent activators of innate immune receptors termed Toll-like receptors 2 and 6.
This study addressed the specific B-cell and T-cell responses directed to lipoproteins in human
S. aureus carriers and non-carriers. 2D immune proteomics and ELISA approaches revealed
that titers of antibodies (IgG) binding to S. aureus lipoproteins were very low. Proliferation
assays and cytokine profiling data showed only subtle responses of T cells; some lipoproteins
did not elicit proliferation. Hence, the robust activation of the innate immune system by S.
aureus lipoproteins does not translate into a strong adaptive immune response. Reasons for
this may include inaccessibility of lipoproteins for B cells as well as ineffective processing and
presentation of the antigens to T cells.
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1 Introduction
The human commensal bacterium Staphylococcus aureus is
found on the skin and mucous membranes [1]. Numerous
studies have shown that about 20 to 30% of the population are
persistent S. aureus nasal carriers [2,3]. In addition, S. aureus
is a major human pathogen causing a wide range of infec-
tions, from relatively mild skin infections such as folliculi-
tis to life-threatening conditions, including deep abscesses,
pneumonia, osteomyelitis, infective endocarditis, and sepsis
[4, 5]. In recent years, resistance of S. aureus strains to the
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Significance of the study
Using an immunoproteomics approach, the study provides
a broad view of the human adaptive immune response to
lipoproteins of S. aureus. It clearly shows that lipoproteins,
well known as triggers of innate immunity, are no prominent
targets of the natural adaptive immune response to S. aureus
in healthy humans; specific IgG serum titers were very low
and T cell responses weak. This suggests that most lipopro-
teins may be inaccessible for B cells and/or ineffectively
presented to T cells in a natural context. We conclude that S.
aureus lipoproteins are powerful adjuvants but poor antigens.
majority of antibiotics has become a global health problem;
not only methicillin but also vancomycin resistances have
been reported [6]. Nosocomial infections with multi-resistant
strains are rapidly spreading globally [5]. For these reasons,
applying immune therapies to control S. aureus remains an
attractive potential therapeutic option.
On an average, S. aureus devotes 2–2.5% of its coding ca-
pacity to lipoproteins, which are attached to the S. aureus
membrane through a di- or triacylglycerol linkage. These are
promising potential immune targets, they are involved in
various functions, including transport and signal transduc-
tion, and contribute to antibiotic resistance [7, 8]. They are
potent TLR2 agonists and activate the TLR2-MyD88 pathway
[9,10]. Heterodimers of TLR2 and TLR6 recognize diacylated
lipopeptides, while complexes of TLR2 and TLR1 sense tri-
acylated lipopeptides [11]. Gram-negative bacteria produce
triacylated lipoproteins, while it remains a matter of debate
whether S. aureus and other Gram-positive bacteria gener-
ate di- and/or triacylated lipoproteins [12]. Ligation of the
TLRs also has a stimulating effect on adaptive immunity,
since S. aureus strains without pro-lipoprotein diacylglyceryl
transferase (Lgt) were impaired in inducing dendritic cell ac-
tivation as well as Th1 and Th17 differentiation [13].
However, the adaptive immune responses to these S. au-
reus lipoproteins are largely unexplored. In animal models,
few studies have focused on the adaptive immune response
using either single lipoproteins or whole bacterial cells. Fer-
ric hydroxamate-binding lipoprotein (FhuD2) vaccination re-
sulted in specific anti-lipoprotein antibodies and conferred
protective immunity in murine infection models [14]. More-
over, a four component S. aureus vaccine containing FhuD2
as one of the antigens elicited broad protection in various
murine models of S. aureus infection when applied with an
adjuvant. This was associated with robust antibody and T cell
responses to the vaccine [15]. Two other lipoproteins, includ-
ing MntC (SitC), a major lipoprotein in S. aureus [16], elicited
IgG and T-cell responses in cattle immunized with intact
S. aureus cells [17]. Regarding the human natural adaptive
immune response to S. aureus lipoproteins, information is
limited. Diep and colleagues measured serum IgG binding
to S. aureus surface proteins in five patients recovering from
S. aureus infection and found mostly low antibody responses
to lipoproteins [18].
In this study, we focused on the humoral and cellular im-
mune response to lipoproteins in healthy S. aureus carriers
as well as non-carriers. In contrast to the vigorous innate
immune response, lipoproteins elicited only subtle antibody
and cellular reactions in naturally exposed adults.
2 Materials and methods
2.1 S. aureus strains and extracellular proteins
The lgt mutation (lgt) confers on S. aureus the ability to
release lipoproteins into the culture medium [16]. A double
mutant, S. aureusRN4220lgtspa, lacking both Lgt and pro-
tein A, was generated as described elsewhere [19] to enable
investigation of the IgG responses at pIs in the acid range,
avoiding non-specific IgG binding to protein A. To isolate
extracellular proteins, bacteria were cultivated in tryptic soy
broth (TSB) at 37C and shaken at 100 linear rpm under iron-
limited conditions in the presence of 600 M 2,2’-bipyridyl
[19]. After 3.5 h in the stationary phase, the bacterial culture
supernatant was filtrated through a 0.22-mfilter and precip-
itated with trichloroacetic acid. Proteins were diluted in RHB
(8 M Urea, 2 M Thiourea, 2% w/v CHAPS) buffer and stored
at −80C [20].
2.2 Human sera and blood cells
A human serum pool was prepared as a mixture of heat-
inactivated sera from 20 healthy donors (four males, 13 fe-
males, and three of unknown sex; age range from 20 to
56 years, unknown S. aureus carriage status) [19]. Heat-
inactivated serum samples from a second cohort of 16 healthy
carriers and 16 healthy non-carriers were used in ELISAs [21].
Samples were stored in aliquots at −80C. Whole blood was
collected from tenhealthy volunteers (fivemales, five females;
ages 22 to 36). All subjects gave their informed consent.
2.3 2D protein separation and immunoblotting
For protein identification, the extracellular bacterial proteins
were first separated on 11-cm Immobiline Dry strips (GE
Healthcare, Munich, Germany) in pI ranges of both 4–7
and 6–11, and then on 12.5% polyacrylamide gels. Gels
were stained with Flamingo (Bio-Rad, Munich, Germany)
and scanned using a Typhoon 9400 scanner (GE Healthcare,
C© 2016 The Authors. Proteomics Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim. www.proteomics-journal.com
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Buckinghamshire, England) at 532 nm with a resolution of
100 m.
For immunoblotting, the extracellular bacterial proteins
were separated by isoelectric focusing on 7-cm Immobiline
Dry Strips (GE Healthcare, Buckinghamshire, England) over
a pI range of 6–10, in the case of strain RN4220 spalgt also
over a pI range of 4–7. In the second dimension, proteins
were subsequently fractionated by molecular mass on 12.5%
SDS polyacrylamide gels. Proteins were then blotted onto a
PVDF membrane (Immobilon-P, Millipore, MS, USA). The
human serum pool was used as source of primary antibody
and incubated with the membrane at a dilution of 1:10,000 in
blocking buffer (140 mMNaCl, 50 mM Tris, 0.1% v/v Tween
20, 5% w/v non-fat milk powder, pH 7.6). IgG binding was
then detected with peroxidase-conjugated goat anti-human
IgG (Dianova, Hamburg, Germany) with a chemilumines-
cent substrate (ECL substrate, SuperSignal West Femto
Maximum Sensitivity Substrate, Pierce, Rockford, IL, USA)
using a ChemoCam HR3200 chemiluminescent scanner
(INTAS, Go¨ttingen, Germany). All experiments were
performed in three technical replicates, and signals were
superimposed using the Delta2D software v4.4 (Decodon,
Greifswald, Germany).
2.4 Protein identification (mass spectrometry)
Protein spots of interest were identified by matching the su-
perimposed 2D immunoblot images with the corresponding
Flamingo-stained 2D gel images by the Delta2D software v4.4
as described elsewhere [22]. Protein identification by MS was
carried out on a Proteome-Analyser 4800 (AB Sciex, Fram-
ingham, USA). GPS explorer v3.6 (AB Sciex) and the MAS-
COT search engine v2.2.02 (Matrix Science, London, Eng-
land) were used to search the obtained peak lists against
a database of protein sequences derived from the genome
sequences of the S. aureus strain USA300 (NC_007793) as
described [19].
2.5 Recombinant S. aureus lipoproteins
Based on MS results and the known protein functions,
we selected eight candidate lipoproteins for further study.
Primers were designed by Primer D’Signer v1.1 (IBA,
Go¨ttingen, Germany) using DNA sequences of S. aureus
strain USA300 (Supporting Information Table S1). To op-
timize protein overexpression, signal peptides and lipid tail
binding sites (Lipobox) were removed as defined by con-
served sequence motifs [7]. The lipoprotein-encoding DNA
fragments were amplified and cloned into the pPR-IBA1 vec-
tor (IBA, Go¨tingen, Germany) to add a C-terminal Strep-
tag for affinity purification of the resulting fusion pro-
tein. The resulting DNA sequences were determined, con-
firming the correct open reading frames (Seqscape v2.6.0,
Applied Biosystems, Foster City, CA, USA). Lipoproteins
were overexpressed in E. coli BL21(DE3)pLysS (Invitrogen,
Carlsbad, CA, USA), which were grown in LB medium (sup-
plemented with 100 g/mL ampicillin and 20 g/mL chlo-
ramphenicol). Expression was induced by adding 0.5 mM
IPTG to cultures shaken at 100 linear rpm at 37C for 3.5 h.
Supernatants of sonication-disrupted cells were applied to
Strep-Tactin columns and affinity purificationwas performed
following the manufacturer’s instructions (IBA, Go¨ttingen,
Germany). Afterwards, recombinant lipoproteins were de-
salted using Spectra/Por 1 (6–8 kDa) membranes (Spectrum,
Rancho Dominguez, CA, USA) and diluted in PBS buffer
without Ca2+ and Mg2+ (Biochrom, Berlin, Germany). Con-
taminating lipopolysaccharides (LPS) were removed by the
use of EndoTrap red columns (Hyglos, Bernried, Germany).
Final LPS concentrations in the experiments were lower than
0.07 ng/mL.
To further increase the number of recombinant lipopro-
teins available for assessment of the antibody response, we
selected 20 additional lipoproteins (see Supporting Informa-
tion Table S1) based on a genome-wide comparison of 15
fully sequenced S. aureus strains, including COL, Newman,
and NCTC8325 [23]. Using LocateP [24], this comparison
predicted a pan-lipoproteome of 118 proteins and a core-
lipoproteome of 40 proteins for the 15 investigated strains.
From the core-lipoproteome, we selected 13 lipoproteins with
poorly characterized or unknown function. Seven additional
lipoproteins of unknown function were selected from the
pan-lipoproteome. These 20 lipoproteins were produced in a
similar way as the eight lipoproteins mentioned above, but
without the LPS depletion step, giving a total number 28
lipoproteins tested in the present study.
RecombinantS. aureusphospholipaseC (Plc) and IsdBpre-
pared as recombinant proteins–without signal peptide, with
C-terminal strep-tag–and depleted of LPS [25] were used as
control antigens.
2.6 ELISA
50 L of 2 g/mL recombinant protein, dissolved in car-
bonate buffer pH 9.0 (CANDOR Bioscience, Wangen, Ger-
many) were used to coat wells of a F96 Cert.MaxiSorp Nunc-
Immuno plate (NUNC, Roskilde, Denmark) overnight at 4C.
The coating solution was discarded, and after washing three
times with PBS-T (137 mM NaCl, 2.7 mM KCl, 10 mM
Na2HPO4, 1.8 mM KH2PO4, 0.05% v/v Tween 20), the plate
was blocked with blocking buffer (2% non-fat milk powder
in PBS-T) for 1 h at room temperature (RT) on a shaker
(50 rpm). Serum samples were used as source of primary
antibody (IgG) at a dilution of 1:100 in the blocking buffer for
1 hour at RT on a shaker (50 rpm). Goat anti-human-IgG
0.8 mg/mL (Jackson ImmunoResearch, West Grove, PA,
USA) was used as the secondary antibody at a dilution
of 1:50 000. Following washing, the plates were incubated
with 3,3’,5,5’ tetramethylbenzidine as substrate (TMB Sub-
strate Reagent Set, BD Biosciences, San Diego, CA, USA)
for 15 minutes and optical density was measured at 450 nm.
The human serum pool described above and PBS (137 mM
C© 2016 The Authors. Proteomics Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim. www.proteomics-journal.com
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NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4)
were used as positive and negative controls, respectively. All
measurements were performed in duplicate, and the means
were used for analysis.
2.7 Cell proliferation assay
Human peripheral-blood mononuclear cells (PBMC) were
isolated from fresh blood of ten healthy volunteers using
Pancoll (PAN-Biotech, Aidenbach, Germany) density gradi-
ent centrifugation. 105 cells per well were cultured in 200 L
R10F medium (RPMI1640 supplemented with 200 U/mL
penicillin, 200 g/mL streptomycin, 4 mM L-glutamine and
10% v/v fetal calf serum). Recombinant proteins were serially
diluted to final concentrations of 25 g/mL to 0.006 g/mL
and used to stimulate PBMCs. The recall antigen tetanus tox-
oid (Statens Serum Institute, Copenhagen, Denmark) was
used as an additional control. Incubation in flat-bottom 96-
well plates was performed for 7 days at 37C in a humidified
atmosphere of 5% CO2. Afterwards, 0.5 Ci/well of tritiated
thymidine (3H-TdR) (PerkinElmer, Boston, USA) was added
to the cell culture and incubation was continued for a fur-
ther 17 h. Proliferation of PBMCs was measured by 3H-TdR
incorporation [25]. All measurements were performed in trip-
licates, and the means are shown.
2.8 Cytokine profiling
Cell culture supernatants of PBMCs incubated with S. au-
reus antigens or controls as described above were collected on
day 7 to optimize sensitivity of cytokine detection. Secreted
cytokines (GM-CSF, IFN-, IL-1, IL-2, IL-3, IL-4, IL-5, IL-6,
IL-8, IL-9, IL-10, IL-12p70, IL-13, IL-17A, TGF-1, TNF) were
measured using Cytometric Bead Array (CBA) Flex Sets (DB,
Heidelberg, Germany) following the manufacturer’s instruc-
tions. Concentrations were determined using FCAP Array
software v3.0 (Soft Flow Inc., St Louis Park, MN, USA). All
measurements were performed in triplicates.
2.9 Statistical analysis
All statistical analyses in this study were performed using
GraphPad Prism v6.02 (GraphPad Software, La Jolla, USA).
Kruskal–Wallis nonparametric tests were conducted to calcu-
late p values. Graphs were visualized by using R v3.1.1 with
the ggplot2 v1.0.0 packet. Significance was set at p0.05 and
is depicted as asterisk symbols with notes in each graph.
3. Results
3.1 Proteomics and immune proteomics of S. aureus
lipoproteins
To investigate the human natural immune response to
lipoproteins, we used S. aureus lgt mutant strains. In the
absence of the enzyme Lgt, lipoproteins have no lipid tails,
and consequently, are more easily released into the medium
in the stationary growth phase [16].
Four S. aureus wild type (WT) strains and their isogenic lgt
mutants (lgt) were examined. The bacteria were grown in
TSB medium under iron limited conditions using 600 M
2,2′-bipyridyl as iron scavenger, which has been shown to
increase the expression of additional highly immunogenic
proteins [19, 26]. Protein extracts derived from the culture
supernatants of WT and isogenic lgtmutants were compared
after separation on 2D gels. In the pI range 6–11, numerous
novel spots were observed in the lgt mutant of strain RN4220
(Fig. 1A). The novel spots were excised and the proteins
identified by MS (Supporting Information Fig. S1, Table
S2). Among them were the isoforms of four lipoproteins:
MntC (SitC), Opp1A, SirA and SstD (Fig. 1A). Similar results
were obtained with the S. aureus strains COL, Newman, and
SA113 (Supporting Information Fig. S2). In the pI range of
4–7, protein-A deletion mutants were used (spa) to avoid
non-specific IgG binding in subsequent tests. RN4220 spa
and lgtspa strains shared very similar spot patterns on the
2D gels, although some spots in the protein extracts of the
lgtspa double mutant strain were of higher intensity. The
corresponding proteins were identified byMS and shown not
to be lipoproteins (Supporting Information Fig. S3). Sixty-
two, 64 and 51 lipoproteins are predicted from the genome
sequences for strains COL, Newman and NCTC8325 (the
parental strains of strains RN4220 and SA113), respectively
[27]. Hence, our proteomic analyses detected less than ten
percent of the potentially expressed lipoproteins.
The proteins separated by 2D SDS-PAGE were transferred
onto membranes and incubated with the human serum
pooled from 20 healthy volunteers. IgG binding to numer-
ous S. aureus proteins present in both WT and lgt mutant of
RN4220 was seen in the pI range of 6–11. In contrast, none
of the lipoproteins selectively released by the RN4220 lgt
mutant was targeted by human serum IgG (Fig. 1B and C,
Supporting Information Fig. S2). Since no lipoproteins with
pI between 4 and 7 were identified, IgG binding was not in-
vestigated in this pI range (Supporting Information Fig. S3).
3.2 Low antibody binding to recombinant S. aureus
lipoproteins
Tobe able to study thehumanantibody response directed toS.
aureus lipoproteins on a broader basis, the four lipoproteins
identified on the immunoblots were expressed in recombi-
nant form.Another four lipoproteinswere selectedwhich per-
form different functions: IsdE is part of the heme transporter
system IsdDEF [28], Opp3A and Opp4A are oligopeptide
ABC transporters [29], and PstS is a periplasmic substrate-
binding protein component of a phosphate ABC transporter
[30]. All eight lipoproteins were cloned from the DNA of the
S. aureus strain USA300. Based on the known signal lipopro-
tein sequence motifs, the signal sequences were removed,
C© 2016 The Authors. Proteomics Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim. www.proteomics-journal.com















Figure 1. Human IgG binding to S. aureus lipoproteins using immunoproteomics. S. aureus extracellular proteins were separated on
2D gels. Proteins were identified by MS (MALDI-TOF). A human serum pool was used as source of IgG for staining immunoblots. The
superimposed images were created with the software Delta2D version 4.4. (A) Superimposed 2D gel images of extracellular proteins
derived from an lgt-competent S. aureus strain RN4220 (orange) and its isogenic lgt mutant (blue). The blue spots represent presumptive
lipoproteins, which are released into the cell culture supernatant. MS analysis identified these proteins as lipoproteins. Superimposed 2D
immunoblots and 2D gel images show the human serum IgG binding to S. aureus extracellular proteins of the WT (B) and the lgt mutant
(C); blue: proteins from S. aureus, orange: IgG-bound proteins. IgG binding to S. aureus lipoproteins was not observed (blue spots in
panels A and C). Similar probing in the pH range 4–7 revealed no secreted lipoproteins (see Supporting Information Fig. S3). Experiments
were carried out in duplicate with similar results.
including the cysteine residue required for Lgt-mediated
lipid tail attachment. A Strep-tag sequence was attached
C-terminally to permit affinity purification on Strep-Tactin
columns. The two extracellular S. aureus antigens, IsdB and
Plc, were generated in a similar way, without signal se-
quence and with a C-terminal Strep-tag, and used as con-
trols. IsdB transports heme to bacterial cells [31] and Plc
degrades membrane inositol phospholipids and releases
glycosyl-phosphatidylinositol-anchored proteins from the cell
surface [32].
The eight recombinant lipoproteins as well as IsdB and Plc
were used as ligands in an ELISA to study serum IgG binding
in a cohort of healthy adults comprising 16 S. aureus carriers
and 16 S. aureus non-carriers. Corroborating the results of
the immunoblots, there was very little if any IgG binding to
the eight lipoproteins (Fig. 2A). The same was true for 20
additional putative lipoproteins (Fig. 2B), which were also ex-
pressed as recombinant proteins without lipid tails. Protein
SaeP (NWMN_0677) was an exception and elicited a moder-
ate antibody response. Carriers and non-carriers did not differ
in serum antibody binding to the recombinant lipoproteins.
In contrast, strong IgG binding to IsdB and Plc was observed,
both in carriers and non-carriers (Fig. 2).
3.3 Regulation of expression of
lipoprotein-encoding genes
Lack of immune priming and generation of specific IgG
antibodies might be explained by weak exposure of B cells
to S. aureus lipoproteins due to their low abundance. This
could be caused by distinct regulation of lipoprotein gene
expression. However, when transcription was profiled in S.
aureus cells grown under different conditions (Supporting
InformationMethods) [33], there were no differences in tran-
scription between lipoprotein genes on the one hand and
those encoding the immunodominant proteins IsdB and Plc
on the other (Supporting Information Fig. S4). This largely
excludes low gene transcription as an explanation for the lack
of lipoprotein-specific serum antibodies. Given similar gene
expression, it was reasoned that due to their anchoring in
the bacterial membrane, the lipoproteins would be released
by S. aureus in lower amounts than proteins with a secretion
signal or signal peptide such as IsdB and Plc. To test this,
the extracellular proteins were quantified in the cell culture
supernatant of the lgt-competent WT S. aureus strain COL
(the same protein extract as depicted in Fig. S2; Methods
in Supporting Information). Indeed, the average extracellu-
lar lipoprotein concentration was at least 10-fold lower than
that of secreted proteins (Supporting Information Fig. S5).
Only eight of the 28 studied lipoproteins (Fig. 2) reached con-
centrations in the same range as the two immunodominant
control proteins IsdB and Plc (data not shown), whereas 13
were present at concentrations below the detection thresh-
old. Of the 62 lipoproteins predicted from the S. aureus COL
genome, only 35 proteins reached the detection limit using
the highly sensitive Nano-LC-MS/MS analysis. This shows
that usually only low amounts of lipoproteins are released by
S. aureus.
C© 2016 The Authors. Proteomics Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim. www.proteomics-journal.com
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Figure 2. Low serum IgG binding to recombinant bacterial lipoproteins. Recombinant lipoproteins (100 ng per cavity) were coated on ELISA
plates and incubated with human serum samples—16 samples from S. aureus non-carriers and 16 samples from S. aureus carriers—each
at a dilution of 1:100. After incubation with the goat anti-human-IgG-POD secondary antibody, IgG binding was measured using TMB
substrate. (A) The absorbance at OD450 nm showed at best weak IgG binding to eight recombinant lipoproteins. IsdB and Plc, known
immunodominant proteins, were included as controls. (B) In addition, 20 putative S. aureus lipoproteins (according to LocateP) were
recombinantly expressed and tested for binding of human serum antibodies as described above. Binding of human serum antibodies
to these proteins was very low as well. Each experiment was repeated twice. Box-and-whisker plots visualize median, upper and lower
quartiles, maximum, minimum and outliers for each dataset.
3.4 T cell proliferation and cytokine secretion in
response to recombinant lipoproteins
We then studied the possible function of lipoproteins
as canonical T-cell antigens. The eight recombinant
lipoproteins devoid of lipid tails, as well as the control anti-
gens Plc and tetanus toxoid (TT), were used to test the hu-
man T-cell response in ten healthy volunteers. As expected,
the control antigens induced a robust proliferation response
already at very low concentrations (0.006 g/mL). Most in-
dividuals have T-cell memory of TT, a typical recall antigen,
and also of Plc, as has been shown previously [25]. The pro-
liferation elicited by the lipoproteins was variable and much
lower than the response to TT or Plc. Opp1A, Opp4A and
SirA did not trigger cell division at all, even at the maximal
concentration of 25 g/mL. MntC (SitC) and SstD triggered
proliferation only at the high concentration of 25 g/mL,
whereas IsdE, Opp3A and PstS induced the cells to respond
at concentrations from 6.25 g/mL. Thus, these lipoproteins
only stimulated weak to moderate proliferation of PBMCs, if
at all (Fig. 3).
To elucidate the quality of the cellular immune response
to lipoproteins without lipid tails, cytokine measurements
were conducted. Supernatants from cultures with moderate
or high proliferation ( 5000 cmp) in response to maximal
antigen concentration (25 g/mL) were selected, and the
following cytokines were measured: GM-CSF, IFN-, IL-1,
IL-2, IL-3, IL-4, IL-5, IL-6, IL-8, IL-9, IL-10, IL-12p70, IL-13,
IL-17A, TGF-1, TNF. The lipoproteins Opp1A, Opp4A and
SirA were excluded from this analysis, since they did not
induce any proliferation in PBMCs. The three lipoproteins
IsdE, Opp3A and PstS (but not MntC (SitC) and SstD) trig-
gered the strongest proliferation and induced the release of
significant concentrations of IFN-, IL-17A, IL-1, IL-12 and
IL-10 (Fig. 4), whereas tetanus toxoid elicited relatively higher
amounts of the Th2 cytokines IL-4, IL-5 and IL-13 as well as
of IL-3 and IL-9. The Th2 bias in the response to the recall
antigen TT has been noted before [25, 34].
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Figure 3. A moderate proliferative response in human PBMCs.
Proliferation assays were conducted to investigate how PBMCs
respond to S. aureus lipoproteins. Fresh human blood samples
from ten individuals were used to isolate PBMCs. Antigens were
applied in serial dilution from 0.006 to 25 g/mL. The recall anti-
gen tetanus toxoid (TT) and the immunodominant protein S.
aureus phospholipase C (Plc) were included as controls. Pro-
liferation was measured by 3H-thymidine incorporation. Exper-
iments were performed in triplicate. Means of the average T-cell
responses of the 10 individuals are depicted. Lipoproteins stimu-
lated PBMCs only at high antigen concentrations (6.25 g/mL).
Three of the five tested lipoproteins (Opp1A, Opp4A and SirA)
did not trigger proliferation at all.
Thus, cytokine release and the proliferative response to
these lipoproteins were positively correlated. The three pro-
teins which moderately stimulated the lymphocytes to di-
vide, IsdE, Opp3A and PstS, also induced the secretion of the
Th1/Th17 cytokines IFN- and IL-17.
4 Discussion
The results of 2D proteomics showed that S. aureus lipopro-
teins were released into culture medium in lgt-deficient S au-
reus strains. The absence of the enzyme Lgt means that there
is no lipid tail attached to the nascent lipoproteins. The result-
ing immature proteins are not anchored in the cytoplasmic
membrane and released from the bacterial cells more eas-
ily [16]. All four lipoproteins that could be identified in the
bacterial supernatants of Lgt-deficient S. aureus participate
in ion transport. MntC (SitC) is a manganese-binding pro-
tein [35]; Opp1A, also known as a NikA-like protein, belongs
to an ABC transporter system for nickel and cobalt [36, 37]
and SirA is required for the acquisition of ferrite Fe(III) [38].
SstD has been shown to interact with ferric catecholamine
and catechol siderophores [39]. Considering that S. aureus
strains have more than 50 genes encoding putative lipopro-
teins [23], the low number of such proteins identified in the
extracellular proteome of Lgt-deficient S. aureus strains is re-
markable, suggesting that most lipoproteins were released in
low amounts.
To investigate the humoral immune response to lipopro-
teins, we used the 2D immunoblotting approach, in which a
serum pool from 20 healthy adults functioned as source of
antibody IgG. Briefly, results on blots (Fig. 1B and C) indi-
cated that there is no antibody binding to the four identified
lipoproteins. In contrast, IgG binding was observed for other
proteins, which are known to be either cell-surface associ-
ated or secreted (for instance Atl, Geh or IsdB) (Supporting
Information Fig. S1). In a second approach, serum IgG bind-
ing to twenty-eight recombinant lipoproteins was tested in
individual S. aureus carriers and non-carriers in comparison
to secreted proteins IsdB and Plc (Fig. 2). It confirmed that
the natural human antibody response to S. aureus lipopro-
teins was very low in S. aureus carriers and non-carriers alike,
irrespective of the function of the tested lipoprotein. An ex-
ception to this was the lipoprotein SaeP, which elicited a
moderate antibody response in human adults. Our results
corroborate the findings of Bagnoli and co-workers, who de-
tected serum antibodies binding to recombinant FhuD2 in
only 13% of healthy adults [15]. This study was designed
to separate the immune function of the lipoprotein protein
component from that of the lipid moiety. Hence, possible
antibody binding to the latter has not been assessed.
Gene expression cannot explain the low immunogenicity
of lipoproteins, since there was no difference in mRNA lev-
els between isdB and plc on the one hand and two genes
(NWMN_1690 and NWMN_2309) encoding lipoproteins de-
void of antibody binding on the other (Supporting Informa-
tion Fig. S4). Moreover, Mishra et al. have demonstrated
that upon bacterial invasion in mice, FhuD2 gene expression
is further upregulated by a factor of 7 [14]. As membrane-
anchored proteins [7, 40, 41] lipoproteins may be covered by
the peptidoglycan layers and thus be inaccessible for the im-
mune system. The crystal structure information available for
IsdE and MntC (SitC) (2Q8P and 4K3V, respectively; protein
database www.pdb.org) provides evidence for the hypothe-
sis. The diameters in the three dimensions of the crystalized
structure of IsdE are 63.53, 63.53, 144.25 A˚ [42], and those
of MntC are 67.48, 68.36, 107.91 A˚ [35]. Hence, the maximal
diameter of these lipoproteins is less than the 300–1000 A˚
thickness of the Gram-positive peptidoglycan layer [43] by a
factor of at least two, suggesting that these proteins may be
largely inaccessible for B cells in intact bacteria. Gautam et al.
corroborated this hypothesis by demonstrating that bacterial
surface glycopolymers prevent antigen recognition by anti-
bodies [44]. In the case of FhuD2, however, it was shown that
lipoproteins can be accessible for antibodies at the bacterial
surface [14].
Gel-free mass spectrometric quantification of the extra-
cellular proteome of S. aureus strain COL, cultured under
iron limited conditions, confirmed that lipoproteins were
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Figure 4. Th1/Th17 cytokine se-
cretion. Cytokine profiling was
conducted on five proliferation-
stimulated lipoprotein assays.
Cytokine secretion during the
proliferative response was an-
alyzed by cytokine bead assay
(BD Biosciences, Heidelberg,
Germany). The three lipopro-
teins IsdE, Opp1A, and PstS
induced the secretion of the
Th1/Th17 cytokines INF- and
IL-17A. Other cytokines, includ-
ing IL-1, IL-10, and IL-12p70,
were also induced by these
lipoproteins. In contrast, MntC
and SstD weakly stimulated the
secretion of cytokines belong-
ing to the Th1/Th17 group (for
details see Supporting Infor-
mation Fig. S6). Kruskal–Wallis
tests were conducted using the
GraphPad Prism v6.02 software
to calculate p values. Asterisks
at the top of each panel corre-
spond to significant differences
to no antigen control as follow-
ing *, p  0.05; **, p  0.01;
***, p 0.001; ****, p 0.0001.
released in much lower amounts than typical secreted S.
aureus proteins, many of which belong to the immunodomi-
nant bacterial subproteome (Supporting Information Fig. S5)
[20,22,45]. However, there are exceptions to this, most promi-
nently MntC, which was found in the bacterial cell culture
supernatant at high concentrations. Moreover, the groups of
Mishra and Diep demonstrated that lipoproteins are upregu-
lated by S. aureus upon invasion on RNA and protein levels,
respectively [14, 18]. Therefore, hiding in the cell wall can-
not explain the lack of a natural human antibody response to
lipoproteins in all cases.
Turning to cellular immunity, lipoproteins could have two
mutually non-exclusive effects: First, they are potent stimula-
tors of innate immune cells, which recognize the lipid tails as
danger signals via TLR2 [46]. Such danger signals are a pre-
requisite for the initiation of an inflammatory T-cell response,
irrespective of the antigen-specificity of the T cells. Studying
infection of mice with an lgt mutant of S. aureus, Schmaler
and co-workers showed that lipoproteins are required for
potent stimulation of T cells, whose antigen-specificity was
not examined. The resulting release of IFN-, IL-17 and IL-10
was dependent on the presence of TLR2 andMyD88 signaling
[13].
In addition to the danger signals conveyed by the lipid
tails, the protein fragment of lipoproteins could prime an
antigen-specific T-cell response. This requires that lipopro-
teins be taken up by antigen-presenting cells, proteolytically
cleaved into peptides, and presented to T cells in complexwith
major histocompatibility complex (MHC) class II molecules.
Such MHC/peptide complexes are recognized by antigen-
specific T cells with the T-cell receptor (TCR). The TCR
is the master switch for activating naı¨ve T cells for prolif-
eration and differentiation into effector T cells, of which
numerous subtypes with specialized functions have been
described [2].
To discriminate the antigen-specific T-cell response to
lipoproteins from non-specific stimulation effects of their
lipid tails, recombinant proteins were generated represent-
ing the protein parts of eight lipoproteins without lipid tails.
Five of the eight tested lipoproteins triggered cell division
to a low or moderate degree in PBMCs of human S. aureus
carriers and non-carriers (Fig. 3), whereas the classical re-
call antigen tetanus toxoid (TT) and the immunodominant
protein Plc induced proliferative responses at a higher rate,
as already indicated in other studies [25]. Opp1A, Opp4A
and SirA did not react at all. MntC and SstD only triggered
C© 2016 The Authors. Proteomics Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim. www.proteomics-journal.com
Proteomics 2016, 16, 2667–2677 2675
lymphocytes at the highest concentration. Inefficient process-
ing and presentation of lipoproteins that are embedded in the
S. aureus cell wall could be among the factors preventing the
generation of a strong cellular immune response to some
members of this group of antigens.
The low grade T-cell reaction to lipoproteins in healthy
adults could be a second factor contributing to the weak hu-
man antibody response to S. aureus lipoproteins. For differ-
entiation into antibody-producing plasma cells, most B cells
need the assistance of T cells in addition to antigen contact
[2].
Cytokine profiling showed that PBMCs responded to
lipoproteins in different ways (Fig. 4 and Supporting Infor-
mation Fig. S6). The three most mitogenic lipoproteins IsdE,
Opp3A and PstS induced production of IFN-, IL-17A, IL-10,
IL-12 and IL-1. This agrees well with the dominant T-cell
reaction profile to S. aureus described by Zielinski and co-
workers as well as in a previous study by our group [25, 47].
In this respect, lipoproteins appear as typical S. aureus anti-
gens.
The production of IFN- and IL-17A confers a protective
immune response by supporting B lymphocyte differentia-
tion to specific IgGproducing cells and recruiting neutrophils
for phagocytosis. Its relevance for protection against S. aureus
was recently demonstrated by Bagnoli and colleagues using
a four component S. aureus vaccine in a murine peritoni-
tis model. Compared to alum, a TLR7-targetting adjuvant
conferred superior protection, which was associated with a
more pronounced Th1/Th17 response profile accompanied
by increased concentrations of specific antibodies of the pro-
inflammatory murine Ig classes IgG2a and IgG2b [15].
Considering the variability in lipoprotein regulation, lo-
cation and function, the universally low antibody and
T-cell responses to a large panel of S. aureus lipoproteins
in healthy adults is remarkable. Clearly, lipoproteins are
not immunologically “silent” per se as has been shown for
FhuD2 and MntC. Immunization of mice with recombi-
nant FhuD2 resulted in a robust antibody response, which
then conferred protection by significantly inhibiting growth
of S. aureus in vivo [14]. Similarly, a four component S.
aureus vaccine containing FhuD2 elicited an antibody re-
sponse in mice [15]. In addition, vaccination of cattle with
heat-killed bacteria elicited antibodies against two lipopro-
teins, NWMN_0601 (MntC) and NWMN_0364. In contrast,
only a slight MntC-specific humoral or cellular immune
response was detectable in humans naturally exposed to S.
aureus in this study aswell as that byDiep and co-workers [18].
Possibly, heat treatment disrupts the bacterial cell wall, thus
facilitating lipoprotein release or exposure, which might ex-
plain the difference in the MntC-directed antibody response
between naturally S. aureus-exposed humans and vaccinated
cattle.
The present study is limited to healthy human adults.
Examining reconvalescent sera of five patients recovering
from an S. aureus infection, Diep et al. observed highly
variable–mostly low–antibody biding to seven lipoproteins
[18]. Recently, our group studied patients with epidermol-
ysis bullosa and cystic fibrosis. These suffer from bar-
rier failure and are subject to repeated S. aureus invasion
over long time periods. Some patients had developed a
moderate IgG response to a subset of lipoproteins includ-
ing MntC (date not shown). Upregulation of lipoprotein
transcription, translation [14, 18] and possibly release upon
S. aureus invasion may have facilitated immune priming in
these patients.
In summary, the present study shows that healthy sub-
jects have only very low antibody (IgG) titers to S. aureus
lipoproteins. It implies that the B cells had not encountered
these proteins in an immunogenic fashion. We propose that
most lipoprotein molecules are buried inside bacterial cell
membranes, and are thus not accessible for B cells. Like-
wise, lymphocyte proliferation and cytokine profiling results
indicated that lipoproteins weakly triggered T-cell responses,
if at all. This may be due to inefficient antigen presenta-
tion to T lymphocytes. However, there could be additional
reasons for the lack of a robust adaptive immune response
to lipoproteins in human adults. It is tempting to specu-
late that the lipid tails decorating the natural lipoproteins
may hamper an effective adaptive immune response. It has
been shown that triggering the innate pattern recognition
receptors TLRs 2/6 by diacylated lipoproteins can induce
immune suppression via myeloid-derived suppressor cells
[48–50].
We conclude from this systematic study that lipoproteins
are no prominent targets of the natural adaptive immune
response to S. aureus in healthy individuals.
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